Browsing by Author Balakrishnar, Bavanthi

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2016Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE studyBalleine, Rosemary; Gao, Bo-Fu; Gebski, Val; Gurney, Howard; Hui, Rina; Kefford, Richard (Rick); Lee, Clara; Liddle, Christopher; Menzies, Alexander Maxwel; Provan, Pamela; Wilcken, Nicholas; Wong, Ka (Mark); Ali, Sayed Sahanawaz; Balakrishnar, Bavanthi; Coulter, Sally A.; Fox, Peter; Lynch, Jodi; Yeap, Shang Heng; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School (Westmead): Office; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study, Clinical Cancer Research, vol.22, 13, 2016,pp 3164-3171
2017Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoringGebski, Val; Liddle, Christopher; Balakrishnar, Bavanthi; Chan, Mathew; Coulter, Sally A.; Fox, Peter; Gurney, Howard; Sabanathan, Dhanusha; Zhang, Alison; NH&MRC Clinical Trials Centre; Westmead Clinical School: MedicineDose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring, Cancer Chemotherapy and Pharmacology, vol.80, 2, 2017,pp 385-393
2012Evidence for Therapeutic Drug Monitoring of Targeted Anticancer TherapiesClements, Arthur; Gao, Bo-Fu; Gurney, Howard; Balakrishnar, Bavanthi; WONG, Mark; Yeap, S; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Evidence for Therapeutic Drug Monitoring of Targeted Anticancer Therapies, Journal of Clinical Oncology, vol.30, 32, 2012,pp 4017-4025
2016Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011Pearson, Sallie-Anne; Turner, Sandra Lynne; Balakrishnar, Bavanthi; Gurney, Howard; Harnett, Paul; Laaksonen, Maarit A; Sabanathan, Dhanusha; Turner, Jennifer Jane; Vajdic, Claire M.; van Leeuwen, Marina T.; Pharmacy; Central Clinical School: MedicinePatterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011, Cancer Epidemiology, vol.43, N/A, 2016,pp 15-21
2014Predictive Value of CYP3A and ABCB1 Phenotyping Probes for the Pharmacokinetics of Sunitinib: the ClearSun StudyBalakrishnar, Bavanthi; Gurney, Howard; Wong, Ka (Mark); Bennink, Roelof; Daali, Youssef; Eechoute, K; Huitema, ADR; Kam, Boen; Kloth, JSL; Klumpen, H J; Mathijssen, Ron; Samer, Caroline; Schellens, J H M; Yu, Huixin; Zwinderman, Aeilko; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Predictive Value of CYP3A and ABCB1 Phenotyping Probes for the Pharmacokinetics of Sunitinib: the ClearSun Study, Clinical Pharmacokinetics, vol.53, 3, 2014,pp 261-269